Option Care Health reports preliminary Q4 revenue $1.46-1.47B, FY2026 guidance $5.8-6.0B; buyback auth doubled to $1B

Option Care Health, Inc.

2025-FY EPS reported $1.27 vs consensus $0.47 ▲ beat (+171.8%)

Q4 2025 preliminary net revenue $1.46-1.47B; GAAP diluted EPS $0.37-0.39; adj. diluted EPS $0.46-0.49.
FY 2025 preliminary net revenue $5.645-5.655B; GAAP diluted EPS $1.27-1.29; adj. diluted EPS $1.72-1.76.
FY 2026 guidance: net revenue $5.8-6.0B; adj. diluted EPS $1.82-1.92; adj. EBITDA $480-505M.
Board increased share repurchase authorization from $500M to $1.0B; repurchased $307M in FY 2025.
Cash flow from operations in FY 2025 below $320M; buyback capacity before expansion was ~$193M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.